Objectives: The effects of excess alcohol consumption (alcohol misuse) on outcomes in patients with acute lung injury have been inconsistent, and there are no studies examining this association in the era of low tidal volume ventilation and a fluid conservative strategy. We sought to determine whether validated scores on the Alcohol Use Disorders Identification Test that correspond to past-year abstinence (zone 1), low-risk drinking (zone 2), mild to moderate alcohol misuse (zone 3), and severe alcohol misuse (zone 4) are associated with poor outcomes in patients with acute lung injury. Design: Secondary analysis. Setting: The Acute Respiratory Distress Syndrome Network, a consortium of 12 university centers (44 hospitals) dedicated to the conduct of multicenter clinical trials in patients with acute lung injury. Subjects: Patients meeting consensus criteria for acute lung injury enrolled in one of three recent Acute Respiratory Distress Syndrome Network clinical trials. Interventions: None.
Measurements and Main Results: Of 1,133 patients enrolled in one of three Acute Respiratory Distress Syndrome Network studies, 1,037 patients had an Alcohol Use Disorders Identification Test score available for analysis. Alcohol misuse was common with 70 (7%) of patients having Alcohol Use Disorders Identification Test scores in zone 3 and 129 (12%) patients in zone 4. There was a U-shaped association between validated Alcohol Use Disorders Identification Test zones and death or persistent hospitalization at 90 days (34% in zone 1, 26% in zone 2, 27% in zone 3, 36% in zone 4; p < 0.05 for comparison of zone 1 to zone 2 and zone 4 to zone 2). In a multiple logistic regression model, there was a significantly higher odds of death or persistent hospitalization in patients having Alcohol Use Disorders Identification Test zone 4 compared with those in zone 2 (adjusted odds ratio 1.70; 95% confidence interval 1.00, 2.87; p = 0.048). Conclusions: Severe but not mild to moderate alcohol misuse is independently associated with an increased risk of death or persistent hospitalization at 90 days in acute lung injury patients. (Crit Care Med 2013; 41:1518-1525) Key Words: acute lung injury; alcohol misuse; alcohol use disorder; alcohol use disorders identification test; unhealthy alcohol use A lcohol misuse is defined as consumption of alcohol in excess of recommended limits and refers to a spectrum of unhealthy drinking (1) . At the milder end of the alcohol misuse spectrum, at-risk drinking is present when consumption exceeds recommended limits, but there are no adverse medical, legal, or social consequences (2, 3) . When drinking leads to medical, legal, or social consequences, by the criteria established in the Diagnostic and Statistical Manual of Mental Disorders, fourth edition, either alcohol abuse or alcohol dependence is present (4) . Validated questionnaires are frequently used as a sensitive screening tool to identify alcohol misuse (5) . Although higher scores on alcohol screening questionnaires do not establish the presence of alcohol abuse or alcohol dependence, generally accepted cutoffs denote an increasing severity of alcohol misuse and a higher probability of alcohol abuse or alcohol dependence (5-7).
An estimated 190,600 cases of acute lung injury (ALI) occur each year in the United States, and despite improvements in treatment, mortality in observational studies continues to approach 40% (8) . Several prior investigations have determined that a history of alcohol abuse independently increases the risk of developing ALI in diverse patient populations. A prospective observational study of 351 critically ill patients demonstrated that a history of alcohol abuse was associated with a two-fold increase in the risk of developing ALI (9) . The association between alcohol abuse and the development of ALI was subsequently confirmed in a multicenter prospective cohort study of patients with septic shock in the United States and in a national survey in the Netherlands (10, 11) . Alcohol abuse has also been identified as a risk factor for transfusion-related acute lung injury (12) and the development of ALI in patients undergoing surgery for lung cancer (13) . However, the relationship between alcohol misuse and outcome in patients with ALI is not clear with a higher mortality in patients with alcohol misuse in one prior observational study and no difference in mortality between patients with and without alcohol misuse in another (9, 11) . Both of these studies were conducted prior to important advancements in ALI including low tidal volume ventilation and a fluid conservative strategy (14, 15) . Furthermore, both of these observational studies focused on short-term outcomes and neither examined the correlation between the severity of alcohol misuse and the outcomes in patients with ALI.
Given the disparate findings regarding the relationship of alcohol misuse and mortality in ALI and the inconsistent definitions regarding alcohol misuse in prior studies, we sought to further clarify the relationship of alcohol misuse with hospital outcomes. We utilized information from large, multicenter investigations of patients with ALI conducted by the ARDS network between 2007 and 2011. Specifically, we sought to determine whether higher alcohol screening scores on the extensively validated Alcohol Use Disorder Identification Test (AUDIT) were independently associated with a combined primary endpoint of mortality or persistent hospitalization at 90 days in patients with ALI. We hypothesized that patients with severe alcohol misuse would have a higher rate of death or persistent hospitalization at 90 days compared with those patients with low-risk alcohol use.
MATERIALS AND METHODS
We performed a secondary analysis of three recently completed multicenter, randomized, double-blind, placebo-controlled trials in patients with ALI. All trials were funded by the National Heart Lung and Blood Institute. Institutional Review Boards at each of the participating institutions for these investigations reviewed and approved study protocols, and informed consent was obtained from patients or their appropriate surrogate prior to enrollment in the parent studies, including later use of collected data. All data was de-identified prior to our analyses.
Data from the three trials was obtained from the ARDS network, a consortium of 12 university centers (44 hospitals) dedicated to the conduct of multicenter clinical trials in patients with ALI. The full inclusion and exclusion criteria for each study are described in the parent manuscripts (16) (17) (18) . Importantly, patients with a Child-Pugh score of 11 or higher were excluded from these studies. The first ARDSNet trial, known as the Albuterol to Treat Acute Lung Injury (ALTA) study, enrolled patients who met American-European Consensus Conference criteria for ALI and required mechanical ventilation (18, 19) . Patients were recruited between August 2007 and July 2008 and randomized to blinded treatment with either aerosolized albuterol or placebo. The second trial, the Omega-3 Fatty Acid/ Antioxidant Supplementation (OMEGA) Study, enrolled ALI patients between January 2008 and February 2009, randomizing them to treatment with either enterally administrated omega-3 fatty acids or placebo. The third study, the Early Versus Delayed Enteral Feeding (EDEN) trial, randomized ALI patients to minimal vs. full enteral feeding and enrolled patients between January 2008 and April 2011. Patients in the ALTA, OMEGA, and EDEN studies received protocolized standard of care incorporating strategies determined to improve in-hospital outcomes, including a fluid conservative and low tidal volume ventilation strategy (14, 15) . There was no significant difference in the primary outcomes between the treatment and the placebo arms in the ALTA, OMEGA, or EDEN studies (16) (17) (18) . For the purpose of investigating our outcome variables, data from patients enrolled in the ALTA, OMEGA, and EDEN studies were combined to form a single dataset for analysis (Fig. 1 ).
Independent Variable: Alcohol Screening Scores
At the time of enrollment, in all three studies, alcohol use was assessed by administering the Alcohol Use Disorders Identification Test (AUDIT) to either the patient or a surrogate. The AUDIT was developed by the World Health Organization and has been validated in several health care settings, including medical inpatients and surrogate decision makers (20, 21) . The AUDIT contains 10 questions assessing alcohol consumption, dependence symptoms, and harmful alcohol use. Each question is scored from 0 to 4 with total scores ranging from 0 (indicating abstinence) to 40. AUDIT scores clinically correlate to abstinence, low-risk drinking, mild to moderate alcohol misuse with a lower risk of alcohol dependence, and severe alcohol misuse (5, 22, 23) . Numerous studies have demonstrated that the established WHO AUDIT cut points should be lowered for women (5, 24, 25) . Accordingly, a priori, we used validated, gender-specific AUDIT cutoffs to categorize patients into one of four zones (Table 1) (7, 24) .
Outcome Variables
For the primary outcome variable, we chose a combined endpoint of mortality or persistent hospitalization at 90 days. Patients who were not home with unassisted breathing at the 90-day follow-up were considered to be persistently hospitalized. This combined endpoint was chosen because survivors of mechanical ventilation who are not discharged home with unassisted breathing are known to have poor outcomes (26) (27) (28) . Similar composite outcomes have been used in prior studies of critical illness (29) . Secondary outcomes included the number of ventilator-free days (VFD) and ICU-free days (ICUFD) out of the 28 days following study entry. As previously described, patients who died prior to study day 28 were considered to have 0 VFD or ICUFD (15, 30) .
Statistical Analysis
Differences among patients in each of the AUDIT zones were compared using analysis of variance or the t test for normally distributed variables. The Wilcoxon rank sum test was used to compare continuous variables that were not normally distributed. Categorical variables were compared using the chisquare test. To determine the association between AUDIT zone and our primary outcome variable, stepwise logistic regression was performed with AUDIT zone as the predictor variable and mortality or persistent hospitalization at 90 days as the outcome variable. Age, severity of illness measured by APACHE III scores, and smoking status (current, former, and never) were chosen a priori to include in the model as confounders. Although age is included in APACHE III scores, age and APACHE III were only weakly associated (r 2 = 0.05), and therefore both were included as covariates in our models. Other variables included in the model were baseline differences in comorbidities (diabetes [31] , immunosuppression, cirrhosis, (32) . Given that hypoalbuminemia is associated with severe alcohol misuse and poor outcomes in the setting of critical illness, we tested the presence of hypoalbuminemia as a mediator once our final model was obtained. As previously described, patients were dichotomized into the presence or absence of hypoalbuminemia based on a cut off of 2 mg/dL (33) . The Hosmer Lemeshow goodness-of-fit statistic was used to ensure adequate model fit.
To test the hypothesis that proper stratification of alcohol use would alter our results, we used a similar logistic regression model to determine whether our results persisted when alcohol screening scores were dichotomized into the absence (zone 1 and zone 2) or presence (zone 3 and zone 4) of alcohol misuse. To analyze the association between AUDIT zone and secondary outcomes, stepwise multiple linear regression was performed using AUDIT category as the predictor variable and ICU or VFDs as the outcome variable while adjusting for age, severity of illness, gender, smoking status, body mass index, and baseline differences in ALI risk factors and comorbidities. A two-sided p value of less than 0.05 was considered to be significant.
The relationship between alcohol consumption and adverse health-related outcomes has been reported to have a "J-shaped" association with mortality, with abstinent individuals having a higher mortality than low-risk drinkers. Individuals who abstain from alcohol are more likely to be older, have greater comorbidity, and poorer health status compared with low-risk drinkers (34, 35) . Therefore, as in multiple prior studies assessing the association between alcohol screening scores and adverse outcomes, we chose a priori to use AUDIT zone 2 (low-risk drinkers) as the referent group for our primary analysis (36) (37) (38) .
RESULTS
Of the 1,133 total patients enrolled in the ALTA, OMEGA, and EDEN studies, 1037 (92%) had an AUDIT score performed and were included in the analysis (Fig. 1) . There was no significant difference in race, age, ALI risk factor, smoking status, APACHE III score, or the primary outcome variable between patients who did and did not have an AUDIT score recorded. However, patients who did not have an AUDIT score recorded were more likely to be male than those who did have one available (63% vs. 51%, p = 0.03). Overall, 70 (7%) and 129 (12%) of patients included in the analysis were in zones 3 and 4, respectively ( Table 2) . Notably, patients in zone 1 were more likely to have comorbidities including immunosuppression, diabetes, and CHF than patients in zones 2-4. Compared with patients in zone 2, those in zone 4 were younger, more likely to be male, more frequently had cirrhosis (Child's Class A or B), less likely to be diabetic, more likely to be a current smoker, and more likely to have aspiration as an ALI risk factor. Overall, patients in AUDIT zones 2 and 3 were similar with respect to their demographic factors, ALI risk factors, and comorbidities, although patients in AUDIT zone 3 were more likely to be current smokers.
On univariate analysis, patients in zone 4 were significantly more likely than those in zone 2 to die or to be persistently hospitalized at 90 days (36% vs. 26%, p = 0.04). Patients in zone 1, who were abstinent from alcohol, were also significantly more likely than those in zone 2 to die or to be persistently hospitalized at 90 days (34% vs. 26%, p = 0.01). Rates of death or persistent hospitalization at 90 days were similar in patients in zone 3 (27%) and zone 2 (26%) (p = 0.88; Fig. 2) . Adjusting for age, gender, severity of illness, smoking status, and baseline differences in ALI risk factor and comorbidities, the significantly higher rate of death or persistent hospitalization in patients in zone 4 compared with zone 2 persisted (adjusted odds ration [OR] 1.78; 95% confidence interval [CI] 1.07, 2.94; p = 0.03;). When hypoalbuminemia was added to this model, there was not a substantial change in the adjusted OR, although hypoalbuminemia was significantly associated with a higher rate of death or persistent hospitalization ( Table 3) . In a simple logistic regression model, there were no higher odds of hypoalbuminemia in patients in zone 4 compared with patients in zone 2 (OR 1.43; 95% CI 0.93, 1.86; p = 0.10). In this model, as well as in the model without hypoalbuminemia, the higher odds of death or persistent hospitalization in patients in zone 1 compared with zone 2 was no longer statistically significant (p = 0.10 and p = 0.06, respectively). Patients with trauma as an ALI risk factor, compared with those without, also had higher odds of death or persistent hospitalization (adjust OR 2.24; 95% CI 1.22, 4.10; p < 0.01).
When AUDIT scores were dichotomized into the presence or absence of alcohol misuse, on univariate analysis, there was no significant difference in the rate of death or persistent hospitalization among patients with alcohol misuse compared with those without (33% vs. 31%, p = 0.71). In multivariate analysis adjusting for age, severity of illness, and baseline differences, the odds of death or persistent hospitalization were similar between those with and without alcohol misuse (adjusted OR 1.22; 95% CI 0.0.82, 1.80; p = 0.32).
In comparing the average number of VFD out of the first 28 after enrollment, patients in zone 4 had significantly fewer VFD than those in zone 2 (Fig. 3) . On average, patients in zone 
DISCUSSION
In this secondary analysis of over 1,000 patients with ALI enrolled in three randomized controlled trials at 12 academic centers and 44 hospitals across the United States, using a validated screening approach, we found that nearly 20% of patients have AUDIT scores that are consistent with alcohol misuse. Further, we observed an independent association between severe alcohol misuse and a combined outcome of mortality or persistent hospitalization at 90 days. This finding is consistent with the initial observation that the presence of alcohol abuse is associated with higher mortality among patients with ALI (65% vs. 35%, p = 0.003) (9) . The lack of an association between alcohol abuse and mortality in the 2003 prospective cohort study may be explained by the fact that low-risk drinkers were grouped with patients with abstinence in the control group, and the screening tool used in that study failed to identify a group of patients with severe alcohol misuse (11) . Supporting this, the association between alcohol use and poor outcomes in this study was no longer present when AUDIT scores were dichotomized into the presence or absence of alcohol misuse. Consistent with the reasoning for our a priori selection of low-risk alcohol use as the proper control group, patients with abstinence were more likely than to have immunosuppression, diabetes, and congestive heart failure. Overall, our findings suggest that the AUDIT, an easily administered screening tool, can be used to identify a subpopulation of ALI patients with a higher risk of adverse outcomes. Several potential biological mechanisms may explain the relationship we observed between severe alcohol misuse and death or persistent hospitalization. Chronic excess alcohol consumption alters expression levels of proinflammatory cytokines (39, 40) , including IL-6 and IL-8 that have been associated with poorer outcomes in the setting of ALI (41) . Moreover, chronic excess alcohol consumption has also been associated with impaired alveolar-capillary permeability both in otherwise healthy people with chronic heavy alcohol consumption (42) and in the setting of sepsis (43) . These permeability effects may be related to decreased alveolar lining concentrations of the antioxidant glutathione (44) . Importantly, low intrapulmonary glutathione is a cardinal feature of ALI (45) . These alcohol-associated effects, alone or in combination, could contribute to protracted illness and poor outcomes among ALI patients with the highest AUDIT scores. Alternatively, the poor outcomes observed in the group with severe alcohol misuse could be secondary to alcohol withdrawal delirium, which is associated with an increase in mortality and longer duration of Some patients had more than 1 acute lung injury risk factor. Thus, the sum of percentages is greater than 100. See Table 1 for a description of the AUDIT zones.
mechanical ventilation in some critically ill patient populations (46) (47) (48) (49) .
Our findings extend the association between AUDIT scores consistent with severe alcohol misuse and adverse medical outcomes previously reported in outpatients and surgical inpatients to the critical care setting (37, 38, 50) . These findings are consistent with prior studies that used administrative databases to demonstrate an association between alcohol dependence and the development of sepsis and septic shock, as well as the need for mechanical ventilation in hospitalized patients (46, 51) . Our findings demonstrate the adverse effects of chronic heavy alcohol consumption in a group of patients that is cared for exclusively in the ICU. The current study has limitations. First, this study is a secondary analysis of three clinical trials in patients with ALI, which were not specifically designed to test our hypothesis. However, the use of data from these three clinical trials allowed us to establish the largest cohort to date of well-characterized ALI patients with alcohol use history collected in a validated consistent fashion to answer our study question. Second, the observed mortality and effect size are smaller than previous observational studies (8, 9, 11) , possibly due to overall improvements in care. However, selection bias should be considered as another potential explanation because the present cohort was comprised of patients enrolled in a clinical trial that excluded moribund patients and those with severe chronic lung or liver disease, who would be most likely to have poor outcomes. Finally, although our primary analysis demonstrated an independent positive association between the highest AUDIT scores and the odds of death or persistent hospitalization at 90 days, our secondary analyses failed to show significant differences in VFD or ICUFD among AUDIT groups in multivariable analyses. This latter finding may suggest that the clinical outcomes for patients in AUDIT zone 4 significantly diverge from those in AUDIT zone 2 only after day 28 of the onset of ALI; alternatively, the number of subjects examined may have had inadequate power to detect differences in these outcome variables.
Although it is clear that exposure to cigarette smoke increases the risk of developing ALI in patients with severe chest trauma, the association between smoking and mortality in ALI has not been examined (52) . Experimental studies provide potential mechanisms by which cigarette smoking may lead to poor outcomes in ALI (53) (54) (55) (56) . We did include smoking status in our multivariate models. However, given Table 1 for a definition of the AUDIT zones. *p < 0.05 compared with zone 2.
recent data that serum biomarkers may more accurately measure exposure to cigarette smoke than a clinical assessment of smoking and that severe alcohol misuse is associated with more severe tobacco dependence, it is possible that our findings may also be due to residual confounding from smoking (57, 58) . Alternatively, exposure to cigarette smoke may moderate the association between severe alcohol misuse and poor outcomes.
CONCLUSIONS
The administration of the AUDIT questionnaire is feasible in the setting of large, multicenter clinical trials enrolling critically ill patients with ALI, and alcohol misuse in such patients remains a significant comorbidity. The presence of severe alcohol misuse according to AUDIT scores in patients with ALI may aid clinicians by identifying individuals who are at higher risk of death or persistent hospitalization at 90 days. Future studies should aim to clarify our understanding of the potential mechanisms that explain these associations.
